Usa Financial Portformulas Corp Regeneron Pharmaceuticals, Inc. Transaction History

Usa Financial Portformulas Corp

$641 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$883.2 - $1071.19 $51,225 - $62,129	58 Added 6.81%	910 $956,000
Q1 2024 Apr 30, 2024	BUY	$902.69 - $993.35 $769,091 - $846,334	852 New	852 $820,000
Q3 2023 Nov 27, 2023	SELL	$692.45 - $844.37 $11,771 - $14,354	-17 Reduced 0.63%	2,695 $2.22 Million
Q2 2023 Nov 27, 2023	SELL	$700.03 - $830.35 $893,238 - $1.06 Million	-1,276 Reduced 32.0%	2,712 $1.95 Million
Q1 2023 Nov 27, 2023	BUY	$680.49 - $826.97 $2.71 Million - $3.3 Million	3,987 Added 398700.0%	3,988 $3.28 Million
Q1 2022 Aug 16, 2022	SELL	$595.12 - $698.43 $1.56 Million - $1.83 Million	-2,618 Reduced 99.96%	1 $1,000
Q4 2021 Feb 10, 2022	BUY	$543.48 - $670.97 $1.42 Million - $1.75 Million	2,613 Added 43550.0%	2,619 $1.65 Million
Q3 2021 Nov 08, 2021	BUY	$574.03 - $680.96 $3,444 - $4,085	6 New	6 $4,000
Q4 2020 Jan 29, 2021	SELL	$478.3 - $607.98 $2.06 Million - $2.62 Million	-4,304 Closed	0 $0
Q3 2020 Oct 09, 2020	SELL	$544.75 - $658.21 $1.62 Million - $1.96 Million	-2,982 Reduced 40.93%	4,304 $2.41 Million
Q2 2020 Aug 11, 2020	SELL	$493.32 - $643.92 $85,837 - $112,042	-174 Reduced 2.33%	7,286 $4.54 Million
Q1 2020 Apr 13, 2020	BUY	$336.18 - $494.43 $2.51 Million - $3.69 Million	7,460 New	7,460 $3.64 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $4.52 Million - $5.26 Million	-16,517 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$299.6 - $414.82 $1.07 Million - $1.49 Million	3,587 Added 27.74%	16,517 $6.78 Million
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $4.36 Million - $5.15 Million	11,705 Added 955.51%	12,930 $5.31 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $411,379 - $493,724	1,225 New	1,225 $495,000
Q3 2018 Oct 31, 2018	SELL	$351.14 - $408.51 $401,353 - $466,926	-1,143 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$284.6 - $344.99 $2,561 - $3,104	-9 Reduced 0.78%	1,143 $394,000
Q1 2018 Apr 03, 2018	BUY	$315.82 - $393.78 $363,824 - $453,634	1,152 New	1,152 $397,000
Q4 2017 Feb 13, 2018	SELL	$358.63 - $469.95 $2.88 Million - $3.77 Million	-8,030 Closed	0 $0
Q3 2017 Nov 02, 2017	SELL	$431.38 - $504.0 $2,588 - $3,024	-6 Reduced 0.07%	8,030 $3.59 Million
Q3 2017 Oct 11, 2017	BUY	$431.38 - $504.0 $3.47 Million - $4.05 Million	8,036	8,036 $3.59 Million

Others Institutions Holding REGN

# of Institutions

1,530

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

News

Stay updated on Usa Financial Portformulas Corp with notifications on news.

Account